Mar 31, 2016

ANI Pharmaceuticals Q1 2016 Earnings Report

Total Revenue
$20.6M
Previous year: $18.8M
+9.3%
EPS
$0.76
Previous year: $0.57
+33.3%
Gross Profit
$17.1M
Previous year: $16M
+6.8%
Cash and Equivalents
$77.7M
Previous year: $166M
-53.0%
Free Cash Flow
$9.6M
Previous year: $1.01M
+852.4%
Total Assets
$292M
Previous year: $266M
+9.6%

ANI Pharmaceuticals

ANI Pharmaceuticals